The combination of budesonide and formoterol exerts more rapid and enhanced anti-inflammatory effects than either drug alone in rat lungs in vivo Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004
Lack of tolerance to the bronchoprotective effect with intermittent administration of salmeterol Source: Eur Respir J 2006; 28: Suppl. 50, 710s Year: 2006
Novel inhibitory effect on 5-lipoxygenase activity by montelukast. Evidence for a noncompetitive mode of action Source: Eur Respir J 2004; 24: Suppl. 48, 96s Year: 2004
The effects of inhaled glucocorticoids on human neutrophil apoptosis Source: Eur Respir J 2001; 18: Suppl. 33, 98s Year: 2001
Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation Source: Eur Respir J, 54 (1) 1802390; 10.1183/13993003.02390-2018 Year: 2019
Do long-acting β2-adrenoceptor agonists enhance the anti-inflammatory effect of glucocorticoids in asthma? Source: Eur Respir J 2001; 17: 1059-1061 Year: 2001
Effect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitro Source: Eur Respir J 2002; 20: Suppl. 38, 91s Year: 2002
The inhibitory effect of salbutamol on neutrophil's respiratory burst is enhanced by the SH-metabolite of erdosteine (mucoactive drug) Source: Eur Respir J 2002; 20: Suppl. 38, 617s Year: 2002
Anti-inflammatory effect of hypoxic signaling suppression in the severe COPD model. Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018
The effect of immunomodulator inferon on oxygen-dependent metabolism of blood cells Source: Eur Respir J 2007; 30: Suppl. 51, 692s Year: 2007
Synergistic effect of fluticasone propionate and salmeterol on T-lymphocytes in inhibiting proliferation in vitro Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009
Inhibitory effect of statins on fibrogenic mediator production from lung cells Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012
In vitro anti-inflammatory activity of the new glucocorticoid ciclesonide in human cellsSource: Eur Respir J 2001; 18: Suppl. 33, 95s Year: 2001
Anti-inflammatory function of tiotropium mediated by suppression of acetylcholine-induced release of chemotactic activity Source: Eur Respir J 2004; 24: Suppl. 48, 318s Year: 2004
Suppressive effects of LABAs over the activation of human MDDCs Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010
CTLA4-Ig enhanced glucocorticoid effect on murine asthma Source: International Congress 2017 – Animal models of asthma and allergies Year: 2017
Synergistic action of the anticholinergic r,r-glycopyrrolate with glucocorticoids and PDE4-inhibitors Source: Eur Respir J 2005; 26: Suppl. 49, 217s Year: 2005
On the possible role of xanthine resistant receptors/sites in the bronchodilator action of adenosine Source: Eur Respir J 2005; 26: Suppl. 49, 579s Year: 2005
Clenbuterol antagonize the effect of chronic administration of steroid respiratory muscle in mice Source: Eur Respir J 2002; 20: Suppl. 38, 496s Year: 2002
Intermittent administration of salmeterol does not induce tolerance to the bronchoprotective effect in exercise induced bronchoconstriction Source: Eur Respir J 2003; 22: Suppl. 45, 497s Year: 2003